ambroxol has been researched along with Respiratory Syndrome, Acute, Severe in 1 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hörnich, BF | 1 |
| Großkopf, AK | 1 |
| Schlagowski, S | 1 |
| Tenbusch, M | 1 |
| Kleine-Weber, H | 1 |
| Neipel, F | 1 |
| Stahl-Hennig, C | 1 |
| Hahn, AS | 1 |
1 other study available for ambroxol and Respiratory Syndrome, Acute, Severe
| Article | Year |
|---|---|
SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
Topics: Ambroxol; Amino Acid Substitution; Angiotensin-Converting Enzyme 2; Bromhexine; Cell Line; COVID-19; | 2021 |